DANIOLABS STARTS TRIAL WITH NEW TREATMENTS FOR PARKINSON'S DISEASE SYMPTOMS

DanioLabs has announced the start of a Phase I proof-of-concept trial of DL06001 and DL06002 for sialorrhoea (drooling) and hyperhidrosis (excessive sweating) in Parkinson's disease, respectively.

The study is being conducted in the UK and is expected to finish later this year. Results are expected to be announced by December 2006.